A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis

Konstan, M. W.; Doering, G.; Heltshe, S. L.; Lands, L. C.; Hilliard, K. A.; Koker, P.; Bhattacharya, S.; Staab, A.; Hamilton, A.

dc.contributor.author	Döring, Gerd
dc.date.accessioned	2014-08-11T13:47:47Z
dc.date.available	2014-08-11T13:47:47Z
dc.date.issued	2014
dc.identifier.issn	1569-1993
dc.identifier.uri	http://hdl.handle.net/10900/55444
dc.language.iso	en	de_DE
dc.publisher	Elsevier Science Bv	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.jcf.2013.12.009	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140610213910_00561	de_DE
utue.publikation.seiten	148-155	de_DE
utue.personen.roh	Konstan, M. W.
utue.personen.roh	Doering, G.
utue.personen.roh	Heltshe, S. L.
utue.personen.roh	Lands, L. C.
utue.personen.roh	Hilliard, K. A.
utue.personen.roh	Koker, P.
utue.personen.roh	Bhattacharya, S.
utue.personen.roh	Staab, A.
utue.personen.roh	Hamilton, A.
dcterms.isPartOf.ZSTitelID	Journal of Cystic Fibrosis	de_DE
dcterms.isPartOf.ZS-Issue	2	de_DE
dcterms.isPartOf.ZS-Volume	13	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE